KFP
BSX icon

KMG Fiduciary Partners’s Boston Scientific BSX Stock Holding History

KMG Fiduciary Partners’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,460
Closed -$235K – 264
2025
Q4 		$235K Sell
2,460
-50
-2% -$4.9K 0.02% 253
2025
Q3 		$245K Buy
2,510
+32
+1% +$3.31K 0.02% 276
2025
Q2 		$266K Hold
2,478
– – 0.02% 264
2025
Q1 		$250K Sell
2,478
-132
-5% -$13.3K 0.02% 260
2024
Q4 		$233K Sell
2,610
-122
-4% -$10.7K 0.02% 260
2024
Q3 		$229K Buy
2,732
+50
+2% +$3.94K 0.02% 255
2024
Q2 		$207K Buy
+2,682
New +$196K 0.02% 237
2021
Q4 		– Sell
-8,156
Closed -$354K – 200
2021
Q3 		$354K Buy
8,156
+327
+4% +$14.5K 0.06% 156
2021
Q2 		$335K Sell
7,829
-650
-8% -$27.3K 0.06% 155
2021
Q1 		$328K Sell
8,479
-34,227
-80% -$1.3M 0.06% 143
2020
Q4 		$1.55M Buy
42,706
+7,810
+22% +$281K 0.33% 70
2020
Q3 		$1.33M Buy
34,896
+134
+0.4% +$5.16K 0.33% 67
2020
Q2 		$1.22M Sell
34,762
-2,197
-6% -$79.1K 0.34% 67
2020
Q1 		$1.21M Buy
36,959
+14,870
+67% +$581K 0.39% 61
2019
Q4 		$999K Buy
+22,089
New +$924K 0.3% 57

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

KMG Fiduciary Partners's BSX Position: Q1 2026 in Review

KMG Fiduciary Partners sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 2,460 shares — an estimated $235K sold.

KMG Fiduciary Partners first reported a position in BSX in Q4 2019 and held it in 15 quarters. The position peaked at $1.55M in Q4 2020. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • KMG Fiduciary Partners reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
  • KMG Fiduciary Partners sold 2,460 Boston Scientific shares in Q1 2026, an estimated $235K.
  • KMG Fiduciary Partners first reported a position in Boston Scientific in Q4 2019 and held it in 15 quarters.
  • KMG Fiduciary Partners's Boston Scientific position peaked at $1.55M in Q4 2020.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on KMG Fiduciary Partners's 13F filing for Q1 2026, filed 13 Apr 2026.